{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:08:38Z","timestamp":1789092518431,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06178-w","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:58:28Z","timestamp":1782471508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between asymmetric dimethylarginine level and central obesity among patients with acute myocardial infarction: exploratory cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ihab A.","family":"Naser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar M.A.","family":"AbuSaada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad K.","family":"Al Qedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"issue":"2","key":"6178_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/157340310791162659","volume":"6","author":"L Sibal","year":"2010","unstructured":"Sibal L, Agarwal SC, Home PD, Boger RH. The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev. 2010;6(2):82\u201390.","journal-title":"Curr Cardiol Rev"},{"issue":"9","key":"6178_CR2","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.3390\/ijms19092605","volume":"19","author":"A Ahmad","year":"2018","unstructured":"Ahmad A, Dempsey SK, Daneva Z, Azam M, Li N, Li PL, et al. Role of nitric oxide in the cardiovascular and renal systems. Int J Mol Sci. 2018;19(9):2605.","journal-title":"Int J Mol Sci"},{"key":"6178_CR3","doi-asserted-by":"publisher","first-page":"101550","DOI":"10.1016\/j.redox.2020.101550","volume":"34","author":"BN Gantner","year":"2020","unstructured":"Gantner BN, Lafond KM, Bonini MG. Nitric oxide in cellular adaptation and disease. Redox Biol. 2020;34:101550.","journal-title":"Redox Biol"},{"issue":"2","key":"6178_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ccc.2019.12.009","volume":"36","author":"AR Cyr","year":"2020","unstructured":"Cyr AR, Huckaby LV, Shiva SS, Zuckerbraun BS. Nitric oxide and endothelial dysfunction. Crit Care Clin. 2020;36(2):307\u201321.","journal-title":"Crit Care Clin"},{"issue":"1","key":"6178_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.17219\/acem\/111808","volume":"29","author":"P Ga","year":"2020","unstructured":"Ga P, Porba M, Jurdziak M, Trzmielewska E, Goclawska K, Derkacz A, et al. Cardiovascular risk factors and the concentration of asymmetric dimethylarginine. Adv Clin Exp Med. 2020;29(1):63\u201370.","journal-title":"Adv Clin Exp Med"},{"issue":"1","key":"6178_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0008-6363(02)00617-X","volume":"57","author":"K Sydow","year":"2003","unstructured":"Sydow K, Schwedhelm E, Arakawa N, Bode-Boger SM, Tsikas D, Hornig B, et al. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inaemia: effects of L-arginine and B vitamins. Cardiovasc Res. 2003;57(1):244\u201352.","journal-title":"Cardiovasc Res"},{"issue":"9299","key":"6178_CR7","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","volume":"358","author":"VP Valkonen","year":"2001","unstructured":"Valkonen VP, Paiva H, Salonen JT, Lakka TA, Lehtimaki T, Laakso J, et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet. 2001;358(9299):2127\u20138.","journal-title":"Lancet"},{"issue":"5","key":"6178_CR8","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1161\/01.RES.0000181286.44222.61","volume":"97","author":"R Schnabel","year":"2005","unstructured":"Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-Klein C, et al. Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene study. Circ Res. 2005;97(5):e53\u20139.","journal-title":"Circ Res"},{"key":"6178_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415\u201345.","journal-title":"Annu Rev Immunol"},{"key":"6178_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000289203","volume":"11","author":"T Tzanavari","year":"2010","unstructured":"Tzanavari T, Giannogonas P, Karalis KP. TNF-alpha and obesity. Curr Dir Autoimmun. 2010;11:145\u201356.","journal-title":"Curr Dir Autoimmun"},{"issue":"4","key":"6178_CR11","first-page":"9797","volume":"37","author":"JK Paik","year":"2015","unstructured":"Paik JK, Kim M, Yen Y, Ahn HY, Lee SH, Lee JH. Circulating Lp-PLA2 activity correlates with oxidative stress and cytokines in overweight\/obese postmenopausal women not using hormone replacement therapy. Age (Dordr). 2015;37(4):9797.","journal-title":"Age (Dordr)"},{"issue":"3","key":"6178_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.23736\/S0026-4806.17.05022-4","volume":"108","author":"S Kachur","year":"2017","unstructured":"Kachur S, Lavie CJ, De Schutter A, Milani RV, Ventura HO. Obesity and cardiovascular diseases. Minerva Med. 2017;108(3):212\u201328.","journal-title":"Minerva Med"},{"issue":"3","key":"6178_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction. Eur Heart J. 2019;40(3):237\u201369.","journal-title":"Eur Heart J"},{"key":"6178_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4137\/CMC.S26624","volume":"9","author":"A Ramirez","year":"2015","unstructured":"Ramirez A, Hu PP. Low high-density lipoprotein and risk of myocardial infarction. Clin Med Insights Cardiol. 2015;9:113\u20137.","journal-title":"Clin Med Insights Cardiol"},{"key":"6178_CR15","volume-title":"Guide to Peripheral and Cerebrovascular Intervention","author":"SS Alam","year":"2004","unstructured":"Alam SS, Bhatt DL, Newby LK. Homocysteine and myocardial infarction. In: Bhatt DL, editor. Guide to Peripheral and Cerebrovascular Intervention. London: Remedica; 2004."},{"issue":"2","key":"6178_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/157340310791162659","volume":"6","author":"L Sibal","year":"2010","unstructured":"Sibal L, Agarwal SC, Home PD, B\u00f6ger RH. The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev. 2010;6(2):82\u201390. https:\/\/doi.org\/10.2174\/157340310791162659.","journal-title":"Curr Cardiol Rev"},{"issue":"3","key":"6178_CR17","first-page":"267","volume":"11","author":"K Mungrue","year":"2011","unstructured":"Mungrue K, Mootoosingh C, Ramsingh S. Epidemiology, risk analysis and clinical outcomes of acute myocardial infarction in Trinidad. Anadolu Kardiyol Derg. 2011;11(3):267\u201370.","journal-title":"Anadolu Kardiyol Derg"},{"issue":"8","key":"6178_CR18","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, Marshall AL, Sj\u00f6str\u00f6m M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395. (PMID: 12900694).","journal-title":"Med Sci Sports Exerc"},{"key":"6178_CR19","volume-title":"Waist circumference and waist\u2013hip ratio: report of a WHO expert consultation","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Waist circumference and waist\u2013hip ratio: report of a WHO expert consultation. Geneva: WHO; 2011."},{"issue":"6","key":"6178_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499\u2013502.","journal-title":"Clin Chem"},{"key":"6178_CR21","unstructured":"Ministry of Health, Palestinian Health Information Center (PHIC). Annual Health Report, Palestine 2020. Nablus: Ministry of Health. 2021. Available from: https:\/\/site.moh.ps\/Content\/Books\/mv2fIO4XVF1TbERz9cwytaKoWKAsRfslLobNuOmj7OPSAJOw2FvOCI_DQYaIXdf2i8gCmPHbCsav29dIHqW26gZu9qJDiW2QsifZt6FrdS4H2.pdf."},{"issue":"1","key":"6178_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12944-020-01248-0","volume":"19","author":"SU Shahid","year":"2020","unstructured":"Shahid SU, Sarwar S. The abnormal lipid profile in obesity and coronary heart disease (CHD) in Pakistani subjects. Lipids Health Dis. 2020;19(1):73.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"6178_CR23","first-page":"630","volume":"31","author":"NA Siddique","year":"2022","unstructured":"Siddique NA, Rahman MS, Islam N, Hossain M, Pathan SU, Parvin IA, Bhowmick K, et al. Estimation of serum lipid profile among patients admitted with myocardial infarction in a tertiary level hospital of Bangladesh. Mymensingh Med J. 2022;31(3):630\u20133.","journal-title":"Mymensingh Med J"},{"issue":"7","key":"6178_CR24","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1161\/ATVBAHA.120.315639","volume":"41","author":"MK Johansen","year":"2021","unstructured":"Johansen MK, Vedel-Krogh S, Nielsen SF, Afzal S, Davey Smith G, Nordestgaard BG. Per-particle triglyceride-rich lipoproteins imply higher myocardial infarction risk than low-density lipoproteins: Copenhagen General Population Study. Arterioscler Thromb Vasc Biol. 2021;41(7):2063\u201375.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"6178_CR25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/0002-9149(92)90550-I","volume":"70","author":"G Assmann","year":"1992","unstructured":"Assmann G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol. 1992;70(7):733\u20137.","journal-title":"Am J Cardiol"},{"issue":"6","key":"6178_CR26","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1161\/01.ATV.17.6.1114","volume":"17","author":"J Jeppesen","year":"1997","unstructured":"Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol. 1997;17(6):1114\u201320.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"6178_CR27","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/jebm.12412","volume":"14","author":"J Wang","year":"2021","unstructured":"Wang J, You D, Wang H, Yang Y, Zhang D, Lv J, et al. Association between homocysteine and obesity: a meta-analysis. J Evid Based Med. 2021;14(3):208\u201317.","journal-title":"J Evid Based Med"},{"issue":"7","key":"6178_CR28","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3390\/nu11071614","volume":"11","author":"Y Wang","year":"2019","unstructured":"Wang Y, Jiang Y, Wang N, Zhu M, Liu X, Wang R, et al. Central but not general obesity is positively associated with the risk of hyperhomocysteinemia in middle-aged women. Nutrients. 2019;11(7):1614.","journal-title":"Nutrients"},{"issue":"6","key":"6178_CR29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S0026-0495(98)90031-2","volume":"47","author":"VA Fonseca","year":"1998","unstructured":"Fonseca VA, Mudaliar S, Schmidt B, Fink LM, Kern PA, Henry RR. Plasma homocysteine concentrations are regulated by acute hyperinsulinaemia in nondiabetic but not type 2 diabetic subjects. Metabolism. 1998;47(6):686\u20139.","journal-title":"Metabolism"},{"issue":"9","key":"6178_CR30","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/j.1440-1746.2005.03891.x","volume":"20","author":"M Gulsen","year":"2005","unstructured":"Gulsen M, Yesilova Z, Bagci S, Uygun A, Ozcan A, Ercin CN, et al. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2005;20(9):1448\u201355.","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"6178_CR31","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1111\/obr.12724","volume":"19","author":"N Wiebe","year":"2018","unstructured":"Wiebe N, Field CJ, Tonelli M. A systematic review of the vitamin B12, folate and homocysteine triad across body mass index. Obes Rev. 2018;19(11):1608\u201318.","journal-title":"Obes Rev"},{"issue":"1","key":"6178_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/BF02913076","volume":"21","author":"AS Yadav","year":"2006","unstructured":"Yadav AS, Bhagwat VR, Rathod IM. Relationship of plasma homocysteine with lipid profile parameters in ischemic heart disease. Indian J Clin Biochem. 2006;21(1):106\u201310.","journal-title":"Indian J Clin Biochem"},{"issue":"1","key":"6178_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jdiacomp.2003.12.003","volume":"19","author":"DA De Luis","year":"2005","unstructured":"De Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. J Diabetes Complications. 2005;19(1):42\u20136.","journal-title":"J Diabetes Complications"},{"issue":"6","key":"6178_CR34","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","volume":"99","author":"D Liao","year":"2006","unstructured":"Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, et al. Hyperhomocysteinaemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein AI protein synthesis and enhancing HDL cholesterol clearance. Circ Res. 2006;99(6):598\u2013606.","journal-title":"Circ Res"},{"issue":"7","key":"6178_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1046\/j.1365-2362.2003.01184.x","volume":"33","author":"T Jonasson","year":"2003","unstructured":"Jonasson T, Hedner T, Hultberg BR, Ohlin H. Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease. Eur J Clin Invest. 2003;33(7):543\u20139.","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"6178_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1080\/00365510310002040","volume":"63","author":"P Wanby","year":"2003","unstructured":"Wanby P, Brattstr\u00f6m L, Brudin L, Hultberg B, Teerlink T. Asymmetric dimethylarginine and total homocysteine in plasma after oral methionine loading. Scand J Clin Lab Invest. 2003;63(5):347\u201353.","journal-title":"Scand J Clin Lab Invest"},{"issue":"8","key":"6178_CR37","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1161\/01.STR.0000131749.81508.18","volume":"35","author":"S Dayal","year":"2004","unstructured":"Dayal S, Arning E, Bottiglieri T, Boger RH, Sigmund CD, Faraci FM, et al. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinaemic mice. Stroke. 2004;35(8):1957\u201362.","journal-title":"Stroke"},{"issue":"12","key":"6178_CR38","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1210\/jc.2004-0672","volume":"89","author":"K Krzyzanowska","year":"2004","unstructured":"Krzyzanowska K, Mittermayer F, Kopp HP, Wolzt M, Schernthaner G. Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocrinol Metab. 2004;89(12):6277\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"6178_CR39","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12944-016-0204-9","volume":"15","author":"H Borgeraas","year":"2016","unstructured":"Borgeraas H, Hertel JK, Seifert R, Berge RK, Bohov P, Ueland PM, Nyg\u00e5rd O, Hjelmes\u00e6th J. Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study. Lipids Health Dis. 2016;15:38.","journal-title":"Lipids Health Dis"},{"issue":"6","key":"6178_CR40","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1161\/01.ATV.0000128897.54893.26","volume":"24","author":"P Vallance","year":"2004","unstructured":"Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylarginine: dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol. 2004;24(6):1023\u201330.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"6178_CR41","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1161\/01.CIR.0000126823.07732.D5","volume":"109","author":"JP Cooke","year":"2004","unstructured":"Cooke JP. Asymmetrical dimethylarginine: the uber marker? Circulation. 2004;109(15):1813\u20138.","journal-title":"Circulation"},{"issue":"9","key":"6178_CR42","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/eurheartj\/ehp061","volume":"30","author":"C Antoniades","year":"2009","unstructured":"Antoniades C, Shirodaria C, Leeson P, Antonopoulos A, Warrick N, Van-Assche T, Cunnington C, Tousoulis D, Pillai R, Ratnatunga C, Stefanadis C, Channon KM. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur Heart J. 2009;30(9):1142\u201350. https:\/\/doi.org\/10.1093\/eurheartj\/ehp061.","journal-title":"Eur Heart J"},{"issue":"12","key":"6178_CR43","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/jcph.179","volume":"53","author":"N Toda","year":"2013","unstructured":"Toda N, Okamura T. Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide: an overview. J Clin Pharmacol. 2013;53(12):1228\u201339.","journal-title":"J Clin Pharmacol"},{"key":"6178_CR44","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3389\/fphar.2019.01033","volume":"10","author":"UM Sundar","year":"2019","unstructured":"Sundar UM, Ugusman A, Chua HK, Latip J, Aminuddin A. Piper sarmentosum promotes endothelial nitric oxide production by reducing asymmetric dimethylarginine in TNF-\u03b1-induced human umbilical vein endothelial cells. Front Pharmacol. 2019;10:1033.","journal-title":"Front Pharmacol"},{"issue":"3","key":"6178_CR45","doi-asserted-by":"publisher","first-page":"234","DOI":"10.31083\/ph.2014.3741","volume":"69","author":"W Feng","year":"2014","unstructured":"Feng W, Sun L, Song Y, Qu XF. Relationship between C-reactive protein and the asymmetric dimethylarginine-induced endothelial dysfunction pathway in vasospastic angina. Pharmazie. 2014;69(3):234\u20137.","journal-title":"Pharmazie"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06178-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06178-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06178-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:02:29Z","timestamp":1789092149000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06178-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6178"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06178-w","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Written institutional approval was obtained from Al-Azhar University-Gaza and the Palestinian Ministry of Health. Written informed consent was obtained from all participants prior to enrolment.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"789"}}